Supreme Court says pharma industry cannot be allowed to run amok under the guise of free market
The Supreme Court has observed that the pharmaceutical sector cannot be left unchecked in the name of a free market. The remarks reflect the court's concern that commercial interests should not override public welfare in healthcare. The observation was made while the court was considering matters related to the regulation of the drug industry. The court emphasized that state oversight remains necessary to protect patients and ensure fair access to medicines. Note: the full article text was not provided, so the summary is limited to the headline's core claim.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in